KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.

The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.   


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://news.cornell.edu/stories/2021/02/antibiotic-tolerance-study-paves-way-new-treatments

https://www.miragenews.com/antibiotic-tolerance-study-paves-way-for-new-516267/



List of Articles
번호 제목 글쓴이 날짜 조회 수
337 허원도 교수, Nature Communications 게재(2013.2) 과사무실 2013.02.21 14523
336 허원도 교수, Mol Cell 과 JMCB 에 논문 게재! 과사무실 2012.06.11 14926
335 허원도 교수, Mai Khanh Nguyen 박사과정 학생 Nature Chemical Biology 논문 게재(2016.04) / Prof. Won Do Heo and Mai Khanh Nguyen Ph.D. published a paper in a Nature Chemical Biology(2016.04) 생명과학과 2016.04.12 13014
334 허원도 교수, ECLIPSE 기술 개발 PNAS지 게재 과사무실 2010.02.09 12643
333 허원도 교수, Chemistry & Biology지 표지논문 게재 과사무실 2014.07.22 14046
332 허원도 교수, 2017년도 4월 「이달의 과학기술인상」 으로 선정 생명과학과 2017.02.07 16763
331 한진희 교수님_카이스트, 뉴런(신경 세포) 교체에 의한 기억저장 규명 생명과학과 2021.11.24 97
330 한진희 교수님_기억이 만들어지는 원리 최초로 규명했다 생명과학과 2021.07.14 355
329 한진희 교수님_ 치매 치료에 열 올리는 KAIST·연구기관 생명과학과 2021.08.18 201
328 한진희 교수님 실험실 (김지은 Post-doc, 권정태 박사과정) Nature Neuroscience 개제 과사무실 2014.01.21 14997
327 한진희 교수, 원혜정 학생(김은준 교수 Lab) 2009' 청암 과학펠로 선정! 과사무실 2009.11.27 14121
326 한진희 교수, 선천적 공포 반응에 대한 신경회로 첫 규명 file 생명과학과 2018.08.08 10899
325 한용만 교수(박상욱 박사과정), Blood 지에 논문 게재! 과사무실 2010.11.19 14759
324 한국, 신종 박테리아 발표건수 68종 세계 1위 - 이성택 교수 세계 2위 과사무실 2005.12.19 13330
323 학사과정 김혜림, 국립암센터 인턴쉽 포스터발표 최우수상 수상 과사무실 2010.09.07 12685
322 학사과정 김유나 학생, 2008학년도 인성장학생으로 선정! 과사무실 2008.12.09 13503
321 학사과정 강병권 학생, 2009년 인성장학생 공로부문 선정! 과사무실 2010.01.08 12094
320 최준호 교수, 한전 석좌교수로 임명 과사무실 2011.09.08 11191
319 최준호 교수, 한국분자-세포생물학회 회장 취임 / Professor Joonho Choe is augurated as the chairman of KSMCB 생명과학과 2016.01.05 11144
318 최준호 교수, 대한민국학술원상 수상! 과사무실 2012.09.18 15251
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 18 Next
/ 18